Rimonabant After Two Years

In data fresh off the presses, rimonabant - the first of a new class of drugs aimed at weight loss and smoking cessation - continues to yield impressive results after two years, with significant weight loss and metabolic improvement, and minimal side effects. Even the critics appear satisfied. So: NOW why can't we have it?